Data gathered: January 13
AI Stock Analysis - Bionano Genomics (BNGO)
Analysis generated January 4, 2025. Powered by Chat GPT.
Bionano Genomics (NASDAQ: BNGO) is a life sciences instrumentation company that develops and markets the Saphyr system. This advanced technology consists of DNA mapping software and is designed to help researchers and clinicians detect structural variations in a genome. This is especially useful in diagnosing complex conditions like genetic disorders and cancers. The company aims at revolutionizing cytogenetic diagnostics and offering significant improvements in the accuracy and efficiency of genome analysis.
Stock Alerts - Bionano Genomics (BNGO)
 |
Bionano Genomics | January 13 Price is down by -7.8% in the last 24h. |
|
Bionano Genomics | January 10 Price is down by -5.4% in the last 24h. |
|
Bionano Genomics | January 8 Price is down by -9.3% in the last 24h. |
|
Bionano Genomics | January 7 Price is down by -5.3% in the last 24h. |
Alternative Data for Bionano Genomics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 1 | Sign up | Sign up | Sign up |
| Sentiment | 75 | Sign up | Sign up | Sign up |
| Webpage traffic | 9,000 | Sign up | Sign up | Sign up |
| Employee Rating | 52 | Sign up | Sign up | Sign up |
| Google Trends | 36 | Sign up | Sign up | Sign up |
| Patents | 23 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 1 | Sign up | Sign up | Sign up |
| Facebook Followers | 2,182 | Sign up | Sign up | Sign up |
| Instagram Followers | 3,909 | Sign up | Sign up | Sign up |
| Reddit Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 7 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 103,618 | Sign up | Sign up | Sign up |
| Twitter Followers | N/A | Sign up | Sign up | Sign up |
| Twitter Mentions | 476 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 2,740 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| ESG | 22 | Sign up | Sign up | Sign up |
| Business Outlook | 7 | Sign up | Sign up | Sign up |
| Linkedin Employees | 192 | Sign up | Sign up | Sign up |
About Bionano Genomics
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight.
| Price | $0.22 |
| Target Price | Sign up |
| Volume | 9,920,000 |
| Market Cap | $32M |
| Year Range | $0.2 - $1.15 |
| Dividend Yield | 0% |
| PE Ratio | 0.03 |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
 |
Bionano Genomics Announces $10 Million Registered Direct OfferingOn January 3, 2025, Bionano Genomics, Inc. (NASDAQ: BNGO) disclosed a definitive agreement with institutional investors for a registered direct offering. The offering involves the purchJanuary 7 - ETF Daily News |
|
Short Interest in Bionano Genomics, Inc. (NASDAQ:BNGO) Increases By 25.1%December 31 - ETF Daily News |
 |
Bionano Genomics stock hits 52-week low at $0.2November 21 - Investing.com |
 |
Bionano Genomics (NASDAQ:BNGO) Cut to Neutral at LADENBURG THALM/SH SHNovember 18 - ETF Daily News |
 |
Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ...November 13 - Yahoo |
 |
Bionano Genomics (BNGO) Q3 2024 Earnings Call TranscriptNovember 13 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 6.1M | 43M | -37M | -44M | -44M | -0.268 |
| Q2 '24 | 12M | 17M | -5M | -16M | -17M | -0.220 |
| Q1 '24 | 8.4M | 26M | -18M | -31M | -31M | -0.510 |
| Q4 '23 | 5.9M | 31M | -25M | -44M | -32M | -0.959 |
| Q3 '23 | 9.2M | 109M | -99M | -113M | -112M | -1.000 |
Insider Transactions View All
| Mamuszka Hannah filed to buy 65,789 shares at $0.8. June 14 '23 |
| Holmlin R. Erik filed to buy 806,474 shares at $0.6. May 16 '23 |
| Stewart Christopher P. filed to buy 281,373 shares at $0.7. May 16 '23 |
| BARKER DAVID L filed to buy 13,894 shares at $1.6. May 18 '22 |
Similar companies
Read more about Bionano Genomics (BNGO) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Bionano Genomics?
The Market Cap of Bionano Genomics is $32M.
What is Bionano Genomics' PE Ratio?
As of today, Bionano Genomics' PE (Price to Earnings) ratio is 0.03.
What is the current stock price of Bionano Genomics?
Currently, the price of one share of Bionano Genomics stock is $0.22.
How can I analyze the BNGO stock price chart for investment decisions?
The BNGO stock price chart above provides a comprehensive visual representation of Bionano Genomics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bionano Genomics shares. Our platform offers an up-to-date BNGO stock price chart, along with technical data analysis and alternative data insights.
Does BNGO offer dividends to its shareholders?
As of our latest update, Bionano Genomics (BNGO) does not offer dividends to its shareholders. Investors interested in Bionano Genomics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Bionano Genomics?
Some of the similar stocks of Bionano Genomics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.